Patent · US Active

Cyclic tripeptide mimetics as plasmin inhibitors

US9133194B2 · kind B2 · utility

0Cited by
0References
18Claims
0Family size

Inventors

Key dates

Filing dateJul 9, 2012
Grant dateSep 15, 2015
Priority date
Expiry dateJul 9, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to peptide mimetics comprising the residues P4-P3-P2-P1, which were cyclized between the side chains of P3 and P2 amino acid and are, as inhibitors of the serine protease plasmin, suitable to be used to inhibit fibrinolysis and thus to reduce blood loss in hyperfibrinolytic conditions, for example during surgery.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.